Related Experiment Video
Updated: Jul 9, 2026
06:33
Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
A tale of two sites - Distinct spatial differences between bone marrow and extramedullary AML
Hossein Emami1, Annette I Garbe1, Karin Huber2
1Department of Hematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel, Germany; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.
Blood Reviews
|July 7, 2026
Summary
Extramedullary acute myeloid leukemia (AML) involves leukemic cells outside the bone marrow and is linked to poor survival. Understanding spatial differences and niche interactions is key for better diagnosis and treatment of this AML subtype.
Area of Science:
- Hematology
- Oncology
- Cancer Biology
Background:
- Acute myeloid leukemia (AML) is a common adult leukemia with poor survival rates.
- Extramedullary (EM) AML, characterized by leukemic infiltration of peripheral tissues, is clinically relevant and associated with adverse outcomes.
- Knowledge regarding extramedullary AML, its drivers, and treatment is less developed compared to bone marrow AML.
Purpose of the Study:
- To review the spatial heterogeneity of AML, distinguishing between bone marrow (BM) and EM disease.
- To elucidate how niche components influence leukemic behavior, clonal evolution, and treatment resistance in EM AML.
- To discuss current clinical practices, diagnostic management, and treatment strategies for EM AML.
Main Methods:
- Review of existing literature on AML, focusing on extramedullary manifestations.
- Analysis of spatial heterogeneity and niche component interactions in AML.
- Evaluation of current clinical approaches and diagnostic tools for EM AML.
Main Results:
- Spatial heterogeneity significantly impacts AML progression, immune evasion, and therapy resistance.
- Niche components in both BM and EM sites play a crucial role in shaping leukemic cell behavior.
- Current clinical management and treatment for EM AML are evolving.
Conclusions:
- Spatial analysis platforms offer transformative potential for mapping cell interactions in EM AML.
- Improved understanding of niche-leukemic cell interactions can enhance diagnosis and personalize therapeutic strategies for EM AML.
- Further research into the spatial biology of EM AML is essential for improving patient outcomes.
Keywords:
Diagnosis of extramedullary AMLExtramedullary AMLMyeloid sarcomaSpatial heterogeneityTreatment of extramedullary AMLMore Related Videos
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:16Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...